|
|
Blood, 1 December 2005, Vol. 106, No. 12, pp. 3995-4001.
Prepublished online as a Blood First Edition Paper on August 18, 2005; DOI 10.1182/blood-2004-11-4338.
Previous Article | Next Article 
Submitted November 15, 2004
Accepted July 28, 2005
Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation. Synergism between IL-10 genotype of patient and IL-10 receptor- genotype of donor
Ming-Tseh Lin, Barry Storer, Paul J Martin, Li-Hui Tseng, Bryan Grogan, Pei-Jer Chen, Lue P Zhao, and John A Hansen*
The Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Pathology, The Albany Medical Center, Albany, NY, USA
The Fred Hutchinson Cancer Research Center, Seattle, WA, USA
The Fred Hutchinson Cancer Research Center, Seattle, WA, USA; School of Medicine, The University of Washington, Seattle, WA, USA
Department of Medical Genetics & Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
College of Medicine, Graduate Institutes of Clinical Medicine, National Taiwan University, Taipei, Taiwan
* Corresponding author; email: jhansen{at}fhcrc.org.
We have previously shown that the IL-10/-592*A allele of the recipient is associated with less severe acute graft-versus-host disease (GVHD) and a lower risk of non-relapse mortality after hematopoietic cell transplantation (HCT) from an HLA-identical sibling. In the present study, we evaluated examined variation in the IL-10 receptor gene as a further test of the hypothesis that the IL-10 pathway regulates the risk of acute GVHD. A single nucleotide polymorphism (A/G) at cDNA position 238 of the IL-10 receptor gene (IL-10RB/c238) was genotyped in 953 HCT recipients and their HLA-identical sibling donors. IL-10/-592 and IL-10RB/c238 genotypes were tested for association with GVHD by multivariable analysis. The IL-10/-592*A allele of the recipient and IL-10RB/c238*G allele of the donor were significantly associated with a lower risk of grades III-IV acute GVHD (trend p values 0.0008 and 0.02, respectively). The donor IL-10RB/c238*G allele provided protection among patients with the IL-10/-592 A/C or A/A genotypes but not among patients with the high risk IL-10/-592 C/C genotype. These data suggest an interaction of the patient IL-10/-592 and donor IL-10RB/c238 genotypes on risk of GVHD, further supporting the hypothesis that the IL-10 pathway plays an important role in controlling the severity of acute GVHD.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Serafini, M. Andreani, M. Testi, M. Battarra, A. Bontadini, E. Biral, K. Fleischhauer, S. Marktel, G. Lucarelli, M. G. Roncarolo, et al.
Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia
Haematologica,
October 1, 2009;
94(10):
1415 - 1426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Y. Bochud, J. W. Chien, K. A. Marr, W. M. Leisenring, A. Upton, M. Janer, S. D. Rodrigues, S. Li, J. A. Hansen, L. P. Zhao, et al.
Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation
N. Engl. J. Med.,
October 23, 2008;
359(17):
1766 - 1777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mullally and J. Ritz
Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation
Blood,
February 15, 2007;
109(4):
1355 - 1362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Takahashi, J. Ooi, A. Tomonari, T. Konuma, N. Tsukada, M. Oiwa-Monna, K. Fukuno, M. Uchiyama, K. Takasugi, T. Iseki, et al.
Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen
Blood,
February 1, 2007;
109(3):
1322 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|